Back to search results

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Solid Tumor · Advanced Solid Tumor · Non-small Cell Lung Cancer · SMARCA4-Deficient Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UCLA, Santa Monica, California, United States

  • University of Colorado Health Hospital, Aurora, Colorado, United States

  • Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States

  • Florida Cancer Specialists ORLANDO/DDU, Lake Mary, Florida, United States

  • University of Miami, Miami, Florida, United States

  • University of Chicago, New Lenox, Illinois, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Columbia University Medical Center, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • Ohio State University Hospital, Columbus, Ohio, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

  • USO-Virginia Cancer Specialists, PC, Fairfax, Virginia, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

  • Institut Bergonie, Bordeaux, France

  • Institut Curie, Paris, France

  • Institut Gustave Roussy-Gustave Roussy Cancer Center -DITEP, Villejuif, France

  • Charite-Universitatsmedizin Berlin, Berlin, Germany

  • Universitaetsklinikum Essen, Essen, Germany

  • Krankenhaus Nordwest, Frankfurt am Main, Germany

  • National Cancer Center Hospital, Chūōku, Japan

  • National Cancer Center Hospital East, Kashiwa, Japan

  • The Cancer Institute Hospital of JFCR, Kōtō City, Japan

  • Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Japan

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • National Cancer Center, Ilsandong-gu, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • The Catholic University of Korea, St. Vincent's Hospital, Suwon, South Korea

  • Hospital Universitari Vall d'Hebron, Barcelona, Spain

  • South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Spain

Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)